Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Sep. 30, 2018 | Nov. 13, 2018 | |
Document And Entity Information [Abstract] | ||
Entity Registrant Name | APPYEA, INC | |
Entity Central Index Key | 1,568,969 | |
Trading Symbol | apyp | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Common Stock, Shares Outstanding | 1,267,789,860 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2018 | |
Amendment Flag | false | |
Document Fiscal Year Focus | 2,019 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Current Assets: | ||
Cash and cash equivalents | $ 22,689 | $ 47,196 |
Total Current Assets | 22,689 | 47,196 |
Fixed assets, net of accumulated depreciation of $257,070 and $250,570 | 800 | 7,300 |
TOTAL ASSETS | 23,489 | 54,496 |
Current Liabilities: | ||
Accounts payable and accrued liabilities | 266,943 | 275,312 |
Accrued salary | 248,000 | 224,000 |
Convertible loans and accrued interest, net of unamortized discounts of $56,994 and $81,968, respectively | 332,887 | 290,823 |
Convertible loans and accrued interest - related party | 9,488 | 8,977 |
Due to related party | 85,689 | 88,087 |
Derivative liability | 1,147,626 | 1,016,865 |
Total Current Liabilities | 2,090,633 | 1,904,064 |
Total Liabilities | 2,090,633 | 1,904,064 |
Stockholders' Deficit: | ||
Convertible preferred stock, $0.0001 par value, 60,000,000 shares authorized, 5,000,000 shares issued and outstanding at June 30, 2018 and 2017, respectively | 500 | 500 |
Common stock, $0.0001 par value, 6,000,000,000 shares authorized, 1,240,477,060 shares issued and outstanding at September 30, 2018 and June 30, 2018, respectively | 124,047 | 124,047 |
Additional paid-in capital | 4,740,277 | 4,740,277 |
Stock payable | 62,727 | 62,727 |
Accumulated deficit | (6,994,695) | (6,777,119) |
Total Stockholders' Deficit | (2,067,144) | (1,849,568) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 23,489 | $ 54,496 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Statement of Financial Position [Abstract] | ||
Accumulated depreciation of fixed assets (in dollars) | $ 257,070 | $ 250,570 |
Convertible loans and accrued interest, unamortized discounts (in dollars) | $ 56,994 | $ 81,968 |
Convertible preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Convertible preferred stock, shares authorized | 60,000,000 | 60,000,000 |
Convertible preferred stock, shares issued | 5,000,000 | 5,000,000 |
Convertible preferred stock, shares outstanding | 5,000,000 | 5,000,000 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized | 6,000,000,000 | 6,000,000,000 |
Common stock, shares issued | 1,240,477,060 | 1,240,477,060 |
Common stock, shares outstanding | 1,240,477,060 | 1,240,477,060 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Income Statement [Abstract] | ||
Revenues | $ 78 | $ 934 |
Total Revenue | 78 | 934 |
Operating Expenses | ||
Legal and professional fees | 9,561 | 64,830 |
General and administrative | 28,257 | 97,236 |
Depreciation | 6,500 | 10,808 |
Total Operating Expenses | 44,318 | 172,874 |
Loss from operations | (44,240) | (171,940) |
Other Expense | ||
Change in fair value of derivative liabilities | (130,761) | (134,237) |
Interest expense | (42,575) | (100,456) |
Net Other Expense | (173,336) | (234,693) |
Net Loss | $ (217,576) | $ (406,633) |
Net Loss Per Common Share: Basic and Diluted (in dollars per share) | $ 0 | $ 0 |
Weighted Average Number of Common Shares Outstanding: Basic and Diluted (in shares) | 1,240,477,060 | 664,499,399 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss | $ (217,576) | $ (406,633) |
Accounts receivable - related party | ||
Depreciation expense | 6,500 | 10,808 |
Amortization of debt discounts | 24,974 | 81,813 |
Change in fair value of derivative liabilities | 130,761 | 134,237 |
Changes in operating assets and liabilities: | ||
Accounts payable and accrued liabilities | (8,369) | 93,263 |
Accrued salary | 24,000 | 24,000 |
Accrued interest | 17,601 | 18,643 |
Net Cash Used in Operating Activities | (22,109) | (43,869) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Issuance of common stock for cash and common stock payable | 200 | |
Proceeds from loan to related party | 4,196 | 1,750 |
Repayment of loan to related party | (6,594) | (100) |
Net cash provided by Financing Activities | (2,398) | 1,850 |
Net cash decrease for period | (24,507) | (42,019) |
Cash at beginning of period | 47,196 | 42,567 |
Cash at end of period | 22,689 | 548 |
SUPPLEMENTAL CASH FLOW INFORMATION: | ||
Cash paid for income taxes | 0 | 0 |
Cash paid for interest | $ 0 | 0 |
NON CASH INVESTING AND FINANCING ACTIVITIES | ||
Issuance of common stock for conversion of debt and accrued interest | 69,284 | |
Resolution of derivative liability upon conversion of debt | 137,170 | |
Derivative liability recognized as debt discount | $ 67,500 |
NATURE OF OPERATIONS
NATURE OF OPERATIONS | 3 Months Ended |
Sep. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
NATURE OF OPERATIONS | 1. NATURE OF OPERATIONS AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history. The Company incorporated a wholly-owned subsidiary, “AppYea Holdings, Inc.” in state of South Dakota on January 13, 2017 and "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017. Through its wholly owned subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics, hospitals, long term care facilities, healthcare groups, and other healthcare providers. The Company's common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Sep. 30, 2018 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES | 2. SIGNIFICANT ACCOUNTING POLICIES The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the company’s management, the accompanying unaudited interim financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the company as of September 30, 2018 and the results of operations and cash flows for the periods presented. The results of operations for the three months ended September 30, 2018 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited financial statements should be read in conjunction with the financial statements and related notes thereto included in the company’s Annual Report on Form 10-K for the year ended June 30, 2018 filed with the SEC on October 15, 2018. Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets. Principles of Consolidation The consolidated financial statements include the accounts of AppYea and its subsidiary. Intercompany transactions and balances have been eliminated. Fair Value of Financial Instruments As defined in ASC 820” Fair Value Measurements,” The following table summarizes fair value measurements by level at September 30, 2018 and June 30, 2018, measured at fair value on a recurring basis: September 30, 2018 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 1,147,626 $ 1,147,626 June 30, 2018 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 1,016,865 $ 1,016,865 |
GOING CONCERN AND LIQUIDITY
GOING CONCERN AND LIQUIDITY | 3 Months Ended |
Sep. 30, 2018 | |
Going Concern And Liquidity [Abstract] | |
GOING CONCERN AND LIQUIDITY | 3. GOING CONCERN AND LIQUIDITY At September 30, 2018, the Company had cash of $22,689 and current liabilities of $2,090,633 and a working capital deficit of $2,067,944. The Company has generated net losses since inception. The Company anticipates future losses in its business. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. There is no assurance that this series of events will be satisfactorily completed. |
FIXED ASSETS
FIXED ASSETS | 3 Months Ended |
Sep. 30, 2018 | |
Property, Plant and Equipment [Abstract] | |
FIXED ASSETS | 4. FIXED ASSETS As at September 30, 2018 and June 30, 2018, the balance of fixed assets represented a vehicle and mobile application software as follows: September 30, June 30, 2018 2018 Mobile applications $ 257,870 $ 257,870 Accumulated depreciation (257,070 ) (250,570 ) Fixed assets, net $ 800 $ 7,300 Depreciation expense for the three months ended September 30, 2018 and 2017 was $6,500 and $10,808, respectively. |
CONVERTIBLE LOANS
CONVERTIBLE LOANS | 3 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
CONVERTIBLE LOANS | 5. CONVERTIBLE LOANS At September 30, 2018 and June 30, 2018, convertible loans consisted of the following: September 30, June 30, 2018 2018 March 2015 Note $ - $ - November 2016 Note -1 150,000 150,000 Convertible notes - Issued in fiscal year 2018 195,614 195,614 Total convertible notes payable 345,614 345,614 Accrued interest 44,267 27,177 Less: Unamortized debt discount (56,994 ) (81,968 ) Total convertible notes 332,887 290,823 Less: current portion of convertible notes 332,887 290,823 Long-term convertible notes $ - $ - During the three months ended September 30, 2018 and 2017, the Company recognized amortization of discount, included in interest expense, of $24,974 and $81,813, respectively. March 2015 Note As of September 30, 2018, and June 30, 2018, the outstanding principal balance of the note was $0, the note had accrued interest of $454. November 2016 Note 1 On November 15, 2016, the Company entered into four separate agreements with Greentree Financial Group, Inc., consisting of a Financial Advisory Agreement, a Loan Agreement, a Convertible Promissory Note, and a Warrant. The Loan Agreement allows for the Company to borrow up to $250,000 from Greentree, which will be evidenced by various promissory notes, which will automatically mature 12 months from the date of applicable Note, will accrue interest at a rate of 12% per annum, and will include an original issuance discount (“OID”) of 10%. In addition, the promissory notes will be convertible at a price equal to 55% of the lowest trading price during the 10 trading days immediately prior to a conversion date. The conversion price shall not be lower than $0.0001. Note may not be converted prior to 6 months from its issuance. There is a 10% prepayment penalty associated with each of the promissory notes. Each promissory note conversion shall result in $1,500 being added to the principal of each promissory note converted. An initial promissory note of $100,000 was issued on November 15, 2016. The warrant issued to Greentree allows for the purchase of up to 5,000,000 shares of the Company’s common stock for a three year period, expiring on November 15, 2019, with an exercise price of $0.03 per share. The warrants also contain a cashless exercise feature, based on a cashless exercise formula. The Company determined that the exercise feature of the warrants met the definition of a liability in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock. The Company will bifurcate the embedded conversion option in the note once the note becomes convertible and account for it as a derivative liability. The fair value of the warrants was recorded as a debt discount being amortized to interest expense over the term of the note. On January 26, 2017 and June 30, 2017, the Company issued convertible notes of $75,000 and $75,000, respectively, according to the loan agreement on November 15, 2016. Promissory Notes - Issued in fiscal year 2018 During the year ended June 30, 2018, the Company issued a total of $180,614 of notes with the following terms: · Terms ranging from 6 months to 12 months. · Annual interest rates of 5% - 12%. · Convertible at the option of the holders at issuance. · Conversion prices are typically based on the discounted (35% to 45% discount) average closing prices or lowest trading prices of the Company’s shares during various periods prior to conversion. Certain notes allow for the conversion price to be a floor of $0.0002 per share. · Certain note allows the principal amount will increase by $15,000 and the discount rate of conversion price will decrease by 15% if the conversion price is less than $$0.01. As a result, the discount rate of conversion price changed from 45% to 60% and the Company recognized the penalty of $15,000 and recorded principal amount of $15,000. Certain notes allow the Company to redeem the notes at rates ranging from 115% to 150% depending on the redemption date provided that no redemption is allowed after the 180th day. Likewise, the note includes original issue discounts and financing costs totaling to $38,447 and the Company received cash of $142,167. Certain convertible notes of $116,666 are currently in default. On June 25, 2018, the Company entered into and closed a financing transaction with Bellridge Capital L.P. consisting of a Securities Purchase Agreement, a Secured Convertible Promissory Note, and a Warrant. The Securities Purchase Agreement provides that Bellridge Capital L.P. would receive a Secured Convertible Promissory Note in an amount of $78,947 in exchange for a funding amount of $78,947, and as additional consideration would also receive a Warrant for the purchase of an additional 394,735,000 shares of common stock. The Convertible Promissory Note will accrue interest at a rate of 5% per annum, default interest at a rate of 24% per annum, and will be convertible at a price equal to the lesser of (i) $0.0002, and (ii) the variable conversion price, which is defined as 65% of the lowest daily VWAP in the twenty (20) Trading Days prior to the Conversion Date . The “market price” is defined as the lowest trading price for the common stock during the twenty-five trading day period ending on the last complete trading day prior to the conversion date. The “trading price” is defined as the lowest trade price on the OTC Pink, OTCQB or applicable trading market. Bellridge Capital L.P. shall not be able to convert the promissory notes in an amount that would result in the beneficial ownership of greater than 4.99% of the outstanding shares of the Company, with the exception that the limitation may be waived by Bellridge Capital L.P. with 61 days prior notice. If, at any time when the note is issued and outstanding, the Company sells or issues shares of common stock for no consideration or for a consideration price per share less than the conversion price in effect on the date of such issuance, the conversion price for the note would be reduced to the amount of the consideration per share received by the Company for such dilutive issuance. If the Company prepays the note on or before 90 days following the date of the note, the Company shall be required to pay 115%, multiplied by the sum of the outstanding principal of the note, plus all accrued and unpaid interest and default interest if any. If the Company prepays the note during the period beginning 91 days and ending 180 days from the issue date of the note, the Company shall be required to pay 120% multiplied by the sum of the then outstanding principal amount of the note, plus accrued and unpaid interest and default interest, if any. If the Company prepays the note during the period beginning after 180 days from the issue date of the note, the Company shall be required to pay 125% multiplied by the sum of the then outstanding principal amount of the note, plus accrued and unpaid interest and default interest, if any. The warrant issued to Bellridge Capital L.P. allows for the purchase of up to 394,735,000 shares of the Company’s common stock for a three-year period with an exercise price of $0.0002 per share. The warrants also contain a cashless exercise feature, based on a cashless exercise formula. In connection with the Secured Promissory Note, the Company entered into a Security Agreement which grants the Debtor a security interest in all of the assets of the Company. Derivative liabilities The Company determined that the exercise feature of the warrants met the definition of a liability in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock. The Company will bifurcate the embedded conversion option in the note once the note becomes convertible and account for it as a derivative liability. The fair value of the warrants was recorded as a debt discount being amortized to interest expense over the term of the note. The Company valued the conversion features using the Black Scholes valuation model. The fair value of the derivative liability for all the note and warrants that became convertible for the year ended June 30, 2018 amounted to $965,401. $277,167 of the value assigned to the derivative liability was recognized as a debt discount to the notes while the balance of $688,234 was recognized as a “day 1” derivative loss. Warrants A summary of activity during the three months ended September 30, 2018 follows: Warrants Outstanding Shares Weighted Average Exercise Price Outstanding, June 30, 2018 592,916,818 $ 0.0004 Granted - - Reset feature - - Exercised - - Forfeited/canceled - - Outstanding, September 30, 2018 592,916,818 $ 0.0004 The following table summarizes information relating to outstanding and exercisable warrants as of September 30, 2018: Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Weighted Average Number of Weighted Average Shares Contractual life (in years) Exercise Price Shares Exercise Price 5,000,000 1.13 $ 0.03 5,000,000 $ 0.03 193,181,818 4.04 $ 0.0001 193,181,818 $ 0.0001 394,735,000 2.74 $ 0.0002 394,735,000 $ 0.0002 592,916,818 3.15 $ 0.0004 592,916,818 $ 0.0004 |
CONVERTIBLE LOANS - RELATED PAR
CONVERTIBLE LOANS - RELATED PARTY | 3 Months Ended |
Sep. 30, 2018 | |
Convertible Loans Related Party [Abstract] | |
CONVERTIBLE LOANS - RELATED PARTY | 6. CONVERTIBLE LOANS – RELATED PARTY At September 30, 2018 and June 30, 2018, convertible loan – related party consisted of the following: September 30, June 30, 2018 2018 Convertible notes - related party -Issued in fiscal year 2018 8,333 8,333 Total convertible notes payable 8,333 8,333 Accrued interest -related party 1,155 644 Less: Unamortized debt discount - related party - - Total convertible notes 9,488 8,977 Less: current portion of convertible notes - related party 9,488 8,977 Long-term convertible notes $ - $ - During the three months ended September 30, 2018 and 2017, the Company recognized amortization of discount, included in interest expense, of $0 and $0, respectively. Promissory Notes - Issued in fiscal year 2018 During the year ended June 30, 2018, the Company issued a total of $8,333 note with the following terms: · Terms of 6 months. · Annual interest rates of 8%. · Convertible at the option of the holders at issuance. · Conversion prices are typically based on the discounted (45% discount) average closing prices of the Company’s shares during 20 days prior to conversion. The Company received cash of $8,333. The Company determined that the conversion feature met the definition of a liability in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity's Own Stock and therefore bifurcated the embedded conversion option once the note becomes convertible and accounted for it as a derivative liability. The fair value of the conversion feature was recorded as a debt discount and amortized to interest expense over the term of the note. The Company valued the conversion feature using the Black Scholes valuation model. The fair value of the derivative liability for all the notes that became convertible, including the notes issued in prior years, during the year ended June 30, 2018 amounted to $9,371. $8,333 of the value assigned to the derivative liability was recognized as a debt discount to the notes while the balance of $1,038 was recognized as a “day 1” derivative loss. |
DERIVATIVE LIABILITIES
DERIVATIVE LIABILITIES | 3 Months Ended |
Sep. 30, 2018 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVE LIABILITIES | 7. DERIVATIVE LIABILITIES The Company analyzed the conversion option for derivative accounting consideration under ASC 815, Derivatives and Hedging, and hedging, and determined that the instrument should be classified as a liability since the conversion option becomes effective at issuance resulting in there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. Fair Value Assumptions Used in Accounting for Derivative Liabilities. ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our derivative liabilities to be a Level 3 fair value measurement and used the Black-Scholes pricing model to calculate the fair value as of September 30, 2018. The Black-Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each convertible note is estimated using the Black-Scholes valuation model. At September 30, 2018, the estimated fair values of the liabilities measured on a recurring basis are as follows: Three months September 30, 2018 Year Ended June 30, 2018 Expected term 0.73 - 4.04 years 0.04 - 5.00 years Expected average volatility 270%-451 % 147%-488 % Expected dividend yield - - Risk-free interest rate 2.36%-2.94 % 0.96%-2.73 % The following table summarizes the changes in the derivative liabilities during the three months ended September 30, 2018: Fair Value Measurements Using Significant Observable Inputs (Level 3) Balance - June 30, 2018 $ 1,016,865 Loss on change in fair value of the derivative 130,761 Balance - September 30, 2018 $ 1,147,626 The aggregate loss on derivatives during the three months ended September 30, 2018 and 2017 was $130,761 and $134,237, respectively. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Sep. 30, 2018 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | 8. COMMITMENTS AND CONTINGENCIES Leases and Long term Contracts The Company has not entered into any long-term leases, contracts or commitments. Agreements In December 2016, the Company entered into a contract agreement with M Endeavors, LLC for marketing the services to Doctors office, clinic and hospitals for the term of 5 years. The Agreements shall automatically renew for successive 12-month periods unless otherwise terminated in accordance with the terms of this Agreement. The Company was required to pay a monthly fee of $8,000 and expenses related to this contract. The Company mutually agreed to terminate this agreement. As of September 30, 2018 and June 30, 2018, the Company recorded accrued expenses of $75,000 and $75,000, respectively. In December 2016, the Company entered into a contract agreement with Big Dreams ventures, LLC for marketing the services to Doctors office, clinic and hospitals for the term of 5 years. The Agreement shall automatically renew for successive 12-month periods unless otherwise terminated in accordance with the terms of this Agreement. The Company was required to pay a monthly fee of $10,000 and expenses related to this contract. The Company mutually agreed to terminate this agreement. As of September 30, 2018 and June 30, 2018, the Company recorded accrued expenses of $105,250 and $105,250, respectively. On October 2, 2017, the Company entered into an agreement with Pacific Pain & Regenerative Medicine. The Company was required to pay $3,000 per month for a collector in exchange for a minimum of 5 PGX tests per week or 20 per month. During the year ended June 30, 2018, the Company terminated the services and stopped making the monthly payments. As of September 30, 2018 and June 30, 2018, the Company recorded accrued expense of $21,000 and $21,000, respectively. On October 17, 2017, the Company entered into an agreement of the acquisition financing of up to $30,000,000 (“the “Placement’) with Wellington Shields $ Co. The Company shall pay (i) a success fee equal to 8% of the gross proceeds of the Placement, (ii) 3% of the total Company’s shares outstanding at the time of closing the placement, and (iii) was required to pay $15,000 at the time of signing and $10,000 per month. This engagement agreement terminated at the close of business April 30, 2018. As of September 30, 2018 and June 30, 2018, the Company recorded accrued expense of $60,000 and $60,000, respectively. Rent As of January 30, 2013, the Company leases office space at $200 per month with three-month terms, which shall be automatically extended for successive three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days’ notice prior to expiration of an applicable term. For the three months ended September 30, 2018 and 2017, the Company incurred $623 and $613, respectively. |
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY | 3 Months Ended |
Sep. 30, 2018 | |
Equity [Abstract] | |
SHAREHOLDERS' EQUITY | 9. SHAREHOLDERS' EQUITY Series A Preferred Stock The Company is authorized to issue 60,000,000 shares of Series A Preferred Stock at a par value of $0.0001. Each Series A preferred share is convertible into 1,500 shares of common stock and has the voting rights of 1,000 shares of common stock. As at September 30, 2018 and June 30, 2018, 5,000,000 shares of the Company's Series A Preferred Stock were issued and outstanding. Common Stock During the three months ended September 30, 2018, there were no issuances of common stock. As at September 30, 2018 and June 30, 2018, 1,240,477,060 shares of the Company's common stock were issued and outstanding. Stock payable The Company had insufficient authorized shares as of June 30, 2017 and as a result, the Company had $105,000 in stock payable for which it is obligated to issue 55,000,000 shares of common stock for consulting services. During the year ended June 30, 2018 the company issued 30,000,000 common shares for cash of $200 and reduced common stock payable by $57,273. As of September 30, 2018, the Company had $47,727 in stock payable for which it is obligated to issue 25,000,000 shares of common stock for consulting services. On November 13, 2017, the Company entered into a consulting agreement with a third party for the term of 5 years with a consideration of an issuance of 40,000,000 shares of common stock valued at $20,000. The share shall be issued in two tranches with first tranche of 10,000,000 shares being due at signing of this agreement and an additional 30,000,000 shares are due on the 3 months anniversary of this agreement. During the year ended June 30, 2018, the Company issued 10,000,000 shares with a fair value of $5,000. As of September 30, 2018, the Company had $15,000 in stock payable for which it is obligated to issue 30,000,000 shares of common stock for consulting services. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Sep. 30, 2018 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | 10. RELATED PARTY TRANSACTIONS In March 2016, the Company appointed current CEO and approved a base compensation package of $8,000 per month for CEO. As of September 30, 2018, and June 30, 2018, the Company recorded accrued salary of $248,000 and $224,000, respectively. During the three months ended September 30, 2018 and 2017, the Company borrowed a total amount of $4,196 and $1,750 from Evergreen Venture Partners LLC (“EVP”), which the CEO is the majority owner, and repaid $6,594 and $100, respectively. This loan is a non-interest bearing and due on demand. As of September 30, 2018, and June 30, 2018, the Company owed EVP, a related party $85,689 and $88,087, respectively. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Sep. 30, 2018 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | 11. SUBSEQUENT EVENTS Subsequent to September 30, 2018, the Company issued 27,312,800 shares of common stock for conversion of debt and accrued interest of $2,185. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (POLICIES) | 3 Months Ended |
Sep. 30, 2018 | |
Accounting Policies [Abstract] | |
Use of Estimates | Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets. |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of AppYea and its subsidiary. Intercompany transactions and balances have been eliminated. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments As defined in ASC 820” Fair Value Measurements,” The following table summarizes fair value measurements by level at September 30, 2018 and June 30, 2018, measured at fair value on a recurring basis: September 30, 2018 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 1,147,626 $ 1,147,626 June 30, 2018 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 1,016,865 $ 1,016,865 |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Accounting Policies [Abstract] | |
Schedule of fair value measurements of financial instruments on recurring basis | September 30, 2018 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 1,147,626 $ 1,147,626 June 30, 2018 Level 1 Level 2 Level 3 Total Assets None $ - $ - $ - $ - Liabilities Derivative liabilities $ - $ - $ 1,016,865 $ 1,016,865 |
FIXED ASSETS (Tables)
FIXED ASSETS (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Property, Plant and Equipment [Abstract] | |
Schedule of fixed assets | September 30, June 30, 2018 2018 Mobile applications $ 257,870 $ 257,870 Accumulated depreciation (257,070 ) (250,570 ) Fixed assets, net $ 800 $ 7,300 |
CONVERTIBLE LOANS (Tables)
CONVERTIBLE LOANS (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
Schedule of convertible loans | September 30, June 30, 2018 2018 March 2015 Note $ - $ - November 2016 Note -1 150,000 150,000 Convertible notes - Issued in fiscal year 2018 195,614 195,614 Total convertible notes payable 345,614 345,614 Accrued interest 44,267 27,177 Less: Unamortized debt discount (56,994 ) (81,968 ) Total convertible notes 332,887 290,823 Less: current portion of convertible notes 332,887 290,823 Long-term convertible notes $ - $ - |
Schedule of warrants activity | Warrants Outstanding Shares Weighted Average Exercise Price Outstanding, June 30, 2018 592,916,818 $ 0.0004 Granted - - Reset feature - - Exercised - - Forfeited/canceled - - Outstanding, September 30, 2018 592,916,818 $ 0.0004 |
Schedule of outstanding and exercisable warrants | Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Weighted Average Number of Weighted Average Shares Contractual life (in years) Exercise Price Shares Exercise Price 5,000,000 1.13 $ 0.03 5,000,000 $ 0.03 193,181,818 4.04 $ 0.0001 193,181,818 $ 0.0001 394,735,000 2.74 $ 0.0002 394,735,000 $ 0.0002 592,916,818 3.15 $ 0.0004 592,916,818 $ 0.0004 |
CONVERTIBLE LOANS - RELATED P_2
CONVERTIBLE LOANS - RELATED PARTY (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Convertible Loans Related Party [Abstract] | |
Schedule of convertible loan-related party | September 30, June 30, 2018 2018 Convertible notes - related party -Issued in fiscal year 2018 8,333 8,333 Total convertible notes payable 8,333 8,333 Accrued interest -related party 1,155 644 Less: Unamortized debt discount - related party - - Total convertible notes 9,488 8,977 Less: current portion of convertible notes - related party 9,488 8,977 Long-term convertible notes $ - $ - |
DERIVATIVE LIABILITIES (Tables)
DERIVATIVE LIABILITIES (Tables) | 3 Months Ended |
Sep. 30, 2018 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of estimated fair values of the liabilities measured on a recurring basis | Three months September 30, 2018 Year Ended June 30, 2018 Expected term 0.73 - 4.04 years 0.04 - 5.00 years Expected average volatility 270%-451 % 147%-488 % Expected dividend yield - - Risk-free interest rate 2.36%-2.94 % 0.96%-2.73 % |
Schedule of changes in the derivative liabilities | Fair Value Measurements Using Significant Observable Inputs (Level 3) Balance - June 30, 2018 $ 1,016,865 Loss on change in fair value of the derivative 130,761 Balance - September 30, 2018 $ 1,147,626 |
SIGNIFICANT ACCOUNTING POLICI_3
SIGNIFICANT ACCOUNTING POLICIES (Details) - Recurring basis - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Assets | ||
Assets | $ 0 | $ 0 |
Liabilities | ||
Derivative liabilities | 1,147,626 | 1,016,865 |
Level 1 | ||
Assets | ||
Assets | 0 | 0 |
Liabilities | ||
Derivative liabilities | 0 | 0 |
Level 2 | ||
Assets | ||
Assets | 0 | 0 |
Liabilities | ||
Derivative liabilities | 0 | 0 |
Level 3 | ||
Assets | ||
Assets | 0 | 0 |
Liabilities | ||
Derivative liabilities | $ 1,147,626 | $ 1,016,865 |
GOING CONCERN AND LIQUIDITY (De
GOING CONCERN AND LIQUIDITY (Detail Textuals) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2017 |
Going Concern And Liquidity [Abstract] | ||||
Cash | $ 22,689 | $ 47,196 | $ 548 | $ 42,567 |
Current liabilities | 2,090,633 | $ 1,904,064 | ||
Working capital deficit | $ 2,067,944 |
FIXED ASSETS - Fixed assets bal
FIXED ASSETS - Fixed assets balance of mobile application software (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Property, Plant and Equipment [Abstract] | ||
Mobile applications | $ 257,870 | $ 257,870 |
Accumulated depreciation | (257,070) | (250,570) |
Fixed assets, net | $ 800 | $ 7,300 |
FIXED ASSETS (Detail Textuals)
FIXED ASSETS (Detail Textuals) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Property, Plant and Equipment [Abstract] | ||
Depreciation expense | $ 6,500 | $ 10,808 |
CONVERTIBLE LOANS (Details)
CONVERTIBLE LOANS (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Short-term Debt [Line Items] | ||
Total convertible notes payable | $ 345,614 | $ 345,614 |
Accrued interest | 44,267 | 27,177 |
Less: Unamortized debt discount | (56,994) | (81,968) |
Total convertible notes | 332,887 | 290,823 |
Less: current portion of convertible notes | 332,887 | 290,823 |
Long-term convertible notes | 0 | 0 |
Convertible promissory note payable | March 2015 Note | ||
Short-term Debt [Line Items] | ||
Total convertible notes payable | 0 | 0 |
Accrued interest | 454 | 454 |
Convertible promissory note payable | November 2016 Note -1 | ||
Short-term Debt [Line Items] | ||
Total convertible notes payable | 150,000 | 150,000 |
Convertible promissory note payable | Convertible notes -Issued in fiscal year 2018 | ||
Short-term Debt [Line Items] | ||
Total convertible notes payable | $ 195,614 | $ 195,614 |
CONVERTIBLE LOANS (Details 1)
CONVERTIBLE LOANS (Details 1) | 3 Months Ended |
Sep. 30, 2018$ / sharesshares | |
Warrant Outstanding, Shares | |
Outstanding, June 30, 2018 | shares | 592,916,818 |
Granted | shares | 0 |
Reset feature | shares | 0 |
Exercised | shares | 0 |
Forfeited/canceled | shares | 0 |
Outstanding, September 30, 2018 | shares | 592,916,818 |
Warrant Outstanding, Weighted Average Exercise Price | |
Outstanding, June 30, 2018 | $ / shares | $ 0.0004 |
Granted | $ / shares | 0 |
Reset feature | $ / shares | 0 |
Exercised | $ / shares | 0 |
Forfeited/canceled | $ / shares | 0 |
Outstanding, September 30, 2018 | $ / shares | $ 0.0004 |
CONVERTIBLE LOANS (Details 2)
CONVERTIBLE LOANS (Details 2) - $ / shares | 3 Months Ended | |
Sep. 30, 2018 | Jun. 30, 2018 | |
Class of Warrant or Right [Line Items] | ||
Warrants Outstanding, Number of Shares | 592,916,818 | 592,916,818 |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0004 | $ 0.0004 |
Warrant One | ||
Class of Warrant or Right [Line Items] | ||
Warrants Outstanding, Number of Shares | 5,000,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 1 year 1 month 17 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.03 | |
Warrants Exercisable, Number of Shares | 5,000,000 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.03 | |
Warrant Two | ||
Class of Warrant or Right [Line Items] | ||
Warrants Outstanding, Number of Shares | 193,181,818 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 4 years 14 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0001 | |
Warrants Exercisable, Number of Shares | 193,181,818 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0001 | |
Warrant Three | ||
Class of Warrant or Right [Line Items] | ||
Warrants Outstanding, Number of Shares | 394,735,000 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 2 years 8 months 26 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0002 | |
Warrants Exercisable, Number of Shares | 394,735,000 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0002 | |
Warrant Four | ||
Class of Warrant or Right [Line Items] | ||
Warrants Outstanding, Number of Shares | 592,916,818 | |
Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 3 years 1 month 24 days | |
Warrants Outstanding, Weighted Average Exercise Price | $ 0.0004 | |
Warrants Exercisable, Number of Shares | 592,916,818 | |
Warrants Exercisable, Weighted Average Exercise Price | $ 0.0004 |
CONVERTIBLE LOANS (Detail Textu
CONVERTIBLE LOANS (Detail Textuals) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||
Jun. 25, 2018USD ($)Day$ / sharesshares | Nov. 15, 2016USD ($)DayMonthAgreement$ / sharesshares | Sep. 30, 2018USD ($)$ / sharesshares | Sep. 30, 2017USD ($) | Jun. 30, 2018USD ($)$ / shares | Jun. 30, 2017USD ($) | Jan. 26, 2017USD ($) | |
Short-term Debt [Line Items] | |||||||
Amortization of discount, included in interest expense | $ 24,974 | $ 81,813 | |||||
Convertible promissory note payable, issued | $ 78,947 | ||||||
Interest rate | 5.00% | ||||||
Number of trading days for lowest traded price | Day | 20 | ||||||
Value of lowest conversion price | $ / shares | $ 0.0002 | ||||||
Interest expense | 42,575 | 100,456 | |||||
Amortization of debt discounts | 24,974 | 81,813 | |||||
Outstanding principle balance of debt | 332,887 | $ 290,823 | |||||
Accrued interest | 44,267 | 27,177 | |||||
Convertible loans and accrued interest, unamortized discounts (in dollars) | $ 56,994 | 81,968 | |||||
Number of notes converted into common stock | shares | 27,312,800 | ||||||
Change in fair value of derivative liabilities | $ (130,761) | $ (134,237) | |||||
Total convertible notes payable | 332,887 | $ 290,823 | |||||
Terms of rang | 6 months | ||||||
Amount of convertible notes default | 116,666 | ||||||
Proceeds from convertible notes payable, net of original issue discounts | $ 142,167 | ||||||
Warrant or right exercisable of common stock Shares | shares | 394,735,000 | ||||||
Exercise price of warrants | $ / shares | $ 0.0004 | $ 0.0004 | |||||
Number of increased in reset features warrants | shares | 0 | ||||||
Warrants exercisable common stock per share | $ / shares | $ 0 | ||||||
Total convertible notes payable | $ 345,614 | $ 345,614 | |||||
Warrant Two | |||||||
Short-term Debt [Line Items] | |||||||
Exercise price of warrants | $ / shares | $ 0.0001 | ||||||
Warrants Exercisable, Number of Shares | shares | 193,181,818 | ||||||
Convertible promissory note payable | Minimum | |||||||
Short-term Debt [Line Items] | |||||||
Percentage of debt instrument redemption | 115.00% | ||||||
Convertible promissory note payable | Maximum | |||||||
Short-term Debt [Line Items] | |||||||
Percentage of debt instrument redemption | 150.00% | ||||||
Convertible promissory note payable | March 2015 Note | |||||||
Short-term Debt [Line Items] | |||||||
Accrued interest | $ 454 | 454 | |||||
Total convertible notes payable | 0 | 0 | |||||
Convertible promissory note payable | November 2016 Note -1 | |||||||
Short-term Debt [Line Items] | |||||||
Total convertible notes payable | 150,000 | 150,000 | |||||
Convertible promissory note payable | November 2016 Note -1 | Greentree Financial Group, Inc | |||||||
Short-term Debt [Line Items] | |||||||
Convertible promissory note payable, issued | $ 250,000 | ||||||
Interest rate | 12.00% | ||||||
Discount percentage of lowest traded price | 55.00% | ||||||
Number of trading days for lowest traded price | Day | 10 | ||||||
Value of lowest conversion price | $ / shares | $ 0.0001 | ||||||
Note convertible, threshold consecutive period | Month | 6 | ||||||
Conversion features, value | $ 1,500 | ||||||
Percentage of issuance discount on note | 10.00% | ||||||
Percentage of prepayment penalty with each promissory note conversion | 10.00% | ||||||
Notes Issued | $ 100,000 | ||||||
Number of common stock called by warrants | shares | 5,000,000 | ||||||
Number of agreement | Agreement | 4 | ||||||
Exercise price of warrants | $ / shares | $ 0.03 | ||||||
Convertible promissory note payable | November 2016 Note -2 | |||||||
Short-term Debt [Line Items] | |||||||
Convertible promissory note payable, issued | $ 75,000 | $ 75,000 | |||||
Convertible promissory note payable | Convertible notes -Issued in fiscal year 2018 | |||||||
Short-term Debt [Line Items] | |||||||
Convertible promissory note payable, issued | $ 180,614 | ||||||
Value of lowest conversion price | $ / shares | $ 0.0002 | ||||||
Total convertible notes payable | $ 195,614 | $ 195,614 | |||||
Discount rate of conversion price if less than $0.01 | 15.00% | ||||||
Principal amount | $ 15,000 | ||||||
Penalty amount | $ 15,000 | ||||||
Discount rate of conversion | 60.00% | ||||||
Convertible promissory note payable | Convertible notes -Issued in fiscal year 2018 | Minimum | |||||||
Short-term Debt [Line Items] | |||||||
Interest rate | 5.00% | ||||||
Discount percentage of lowest traded price | 35.00% | ||||||
Terms of rang | 6 months | ||||||
Convertible promissory note payable | Convertible notes -Issued in fiscal year 2018 | Maximum | |||||||
Short-term Debt [Line Items] | |||||||
Interest rate | 12.00% | ||||||
Terms of rang | 12 months |
CONVERTIBLE LOANS (Detail Tex_2
CONVERTIBLE LOANS (Detail Textuals 1) | 1 Months Ended | 3 Months Ended | ||
Jun. 25, 2018USD ($)Day$ / sharesshares | Sep. 30, 2018USD ($)$ / shares | Sep. 30, 2017USD ($) | Jun. 30, 2018USD ($)$ / shares | |
Short-term Debt [Line Items] | ||||
Additional shares of common stock | shares | 394,735,000 | |||
Principal amount of promissory Note | $ 78,947 | |||
Interest rate | 5.00% | |||
Conversion price | $ / shares | $ 0.0002 | |||
Number of trading days for lowest traded price | Day | 20 | |||
Exercise price of warrants | $ / shares | $ 0.0004 | $ 0.0004 | ||
Fair value of derivative liability | $ 965,401 | |||
Derivative liability recognized as debt discount | $ 67,500 | |||
Derivative loss | $ 688,234 | |||
Bellridge Capital L.P | Warrant | ||||
Short-term Debt [Line Items] | ||||
Additional shares of common stock | shares | 394,735,000 | |||
Description of notice for agreement | If the Company prepays the note on or before 90 days following the date of the note, the Company shall be required to pay 115%, multiplied by the sum of the outstanding principal of the note, plus all accrued and unpaid interest and default interest if any. If the Company prepays the note during the period beginning 91 days and ending 180 days from the issue date of the note, the Company shall be required to pay 120% multiplied by the sum of the then outstanding principal amount of the note, plus accrued and unpaid interest and default interest, if any. If the Company prepays the note during the period beginning after 180 days from the issue date of the note, the Company shall be required to pay 125% multiplied by the sum of the then outstanding principal amount of the note, plus accrued and unpaid interest and default interest, if any. | |||
Term of warrant | 3 years | |||
Exercise price of warrants | $ / shares | $ 0.0002 |
CONVERTIBLE LOANS - RELATED P_3
CONVERTIBLE LOANS - RELATED PARTY (Details) - USD ($) | Sep. 30, 2018 | Jun. 30, 2018 |
Convertible Loans Related Party [Abstract] | ||
Convertible notes - related party -Issued in fiscal year 2018 | $ 8,333 | $ 8,333 |
Total convertible notes payable | 8,333 | 8,333 |
Accrued interest -related party | 1,155 | 644 |
Less: Unamortized debt discount - related party | 0 | 0 |
Total convertible notes | 9,488 | 8,977 |
Less: current portion of convertible notes - related party | (9,488) | (8,977) |
Long-term convertible notes | $ 0 | $ 0 |
CONVERTIBLE LOANS - RELATED P_4
CONVERTIBLE LOANS - RELATED PARTY (Detail Textuals) - USD ($) | 3 Months Ended | 12 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2018 | |
Short-term Debt [Line Items] | |||
Amortization of debt discounts | $ 24,974 | $ 81,813 | |
Proceeds from issuance of promissory notes | $ 8,333 | ||
Term of promissory notes | 6 months | ||
Annual interest rate | 8.00% | ||
Discounted conversion rate on average closing price | 45.00% | ||
Fair value of derivative liability | $ 965,401 | ||
Derivative liability recognized as debt discount to notes | 8,333 | ||
Derivative loss | 688,234 | ||
CONVERTIBLE LOANS - RELATED PARTY | |||
Short-term Debt [Line Items] | |||
Amortization of debt discounts | $ 0 | $ 0 |
DERIVATIVE LIABILITIES (Details
DERIVATIVE LIABILITIES (Details) | 3 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Jun. 30, 2018 | |
Minimum | ||
Derivative [Line Items] | ||
Expected term | 8 months 23 days | 15 days |
Expected average volatility | 270 | 147 |
Risk-free interest rate | 2.36% | 0.96% |
Maximum | ||
Derivative [Line Items] | ||
Expected term | 4 years 15 days | 5 years |
Expected average volatility | 451 | 488 |
Risk-free interest rate | 2.94% | 2.73% |
DERIVATIVE LIABILITIES (Detai_2
DERIVATIVE LIABILITIES (Details 1) | 3 Months Ended |
Sep. 30, 2018USD ($) | |
Derivative Liabilities Roll Forward | |
Balance - June 30, 2018 | $ 1,016,865 |
Loss on change in fair value of the derivative | 130,761 |
Balance - September 30, 2018 | $ 1,147,626 |
DERIVATIVE LIABILITIES (Detail
DERIVATIVE LIABILITIES (Detail Textuals) - USD ($) | 3 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||
Aggregate loss on derivatives | $ (130,761) | $ (134,237) |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Detail Textuals) - USD ($) | Oct. 02, 2017 | Oct. 17, 2017 | Dec. 31, 2016 | Jan. 30, 2013 | Sep. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2018 |
Commitments And Contingencies [Line Items] | |||||||
Lease and rental expense | $ 200 | $ 623 | $ 613 | ||||
Leases, term of contract | 3 months | ||||||
Description of lease term | Three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term. | ||||||
Contract agreement | M Endeavors, Llc | |||||||
Commitments And Contingencies [Line Items] | |||||||
Term of agreement for marketing services to Doctors office, clinic and hospitals | 5 years | ||||||
Additonal term of agreement on renewation | 12 months | ||||||
Monthly fee and expenses paid | $ 10,000 | ||||||
Accrued expenses | 75,000 | $ 75,000 | |||||
Contract agreement | Big Dreams Ventures, Llc | |||||||
Commitments And Contingencies [Line Items] | |||||||
Term of agreement for marketing services to Doctors office, clinic and hospitals | 5 years | ||||||
Additonal term of agreement on renewation | 12 months | ||||||
Monthly fee and expenses paid | $ 10,000 | ||||||
Accrued expenses | 105,250 | 105,250 | |||||
Contract agreement | Pacific Pain & Regenerative Medicine | |||||||
Commitments And Contingencies [Line Items] | |||||||
Monthly fee and expenses paid | $ 3,000 | ||||||
Number of PGX tests collected per week | 5 | ||||||
Number of PGX tests collected per month | $ 20 | ||||||
Accrued expenses | 21,000 | 21,000 | |||||
Placement agreement | Wellington Shields $ Co. | |||||||
Commitments And Contingencies [Line Items] | |||||||
Accrued expenses | $ 60,000 | $ 60,000 | |||||
Agreement, value | $ 30,000,000 | ||||||
Percentage of proceeds from agreement | 8.00% | ||||||
Percentage of total shares outstanding | 3.00% | ||||||
Agreement signing amount, paid | $ 15,000 | ||||||
Agreement, monthly payment | $ 10,000 |
SHAREHOLDERS' EQUITY (Detail Te
SHAREHOLDERS' EQUITY (Detail Textuals) - USD ($) | Nov. 13, 2017 | Sep. 30, 2018 | Jun. 30, 2018 |
Shareholders Equity [Line Items] | |||
Number of common stock issued for services | 30,000,000 | ||
Amount of common stock issued for cash | $ 200 | ||
Stock issued period for common stock payable | $ 57,273 | ||
Common stock, shares authorized | 6,000,000,000 | 6,000,000,000 | |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Convertible preferred stock, shares authorized | 60,000,000 | 60,000,000 | |
Convertible preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | |
Convertible preferred stock, number of shares issued on conversion | 1,500 | ||
Convertible preferred stock, voting rights | voting rights of 1,000 shares of common stock. | ||
Convertible preferred stock, shares issued | 5,000,000 | 5,000,000 | |
Convertible preferred stock, shares outstanding | 5,000,000 | 5,000,000 | |
Common stock, shares issued | 1,240,477,060 | 1,240,477,060 | |
Common stock, shares outstanding | 1,240,477,060 | 1,240,477,060 | |
Number of shares payable for service | 25,000,000 | 55,000,000 | |
Amount of Stock payable, common shares | $ 47,727 | $ 105,000 | |
Due on signing of agreement | |||
Shareholders Equity [Line Items] | |||
Number of shares payable for service | 10,000,000 | 10,000,000 | |
Amount of common stock issued for services | $ 5,000 | ||
3 months anniversary of agreement | |||
Shareholders Equity [Line Items] | |||
Number of shares payable for service | 30,000,000 | ||
Consulting agreement | |||
Shareholders Equity [Line Items] | |||
Number of shares payable for service | 40,000,000 | ||
Amount of Stock payable, common shares | $ 20,000 | $ 15,000 | |
Stock payable, common shares (in shares) | 30,000,000 | ||
Initial term of Management Services Agreement | 5 years |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Detail Textuals) - USD ($) | 1 Months Ended | 3 Months Ended | ||
Mar. 31, 2016 | Sep. 30, 2018 | Sep. 30, 2017 | Jun. 30, 2018 | |
Related Party Transaction [Line Items] | ||||
Accrued salaries | $ 248,000 | $ 224,000 | ||
Proceeds from convertible notes payable - related party, net of original issue discounts | 4,196 | $ 1,750 | ||
Repayment to EVP | 6,594 | $ 100 | ||
Amount owed to Evergreen Venture Partners LLC ("EVP") | $ 85,689 | $ 88,087 | ||
CEO | ||||
Related Party Transaction [Line Items] | ||||
Base compensation package per month | $ 8,000 |
SUBSEQUENT EVENTS (Detail Textu
SUBSEQUENT EVENTS (Detail Textuals) | 3 Months Ended |
Sep. 30, 2018USD ($)shares | |
Subsequent Event [Line Items] | |
Shares of common stock for conversion of debt | shares | 27,312,800 |
Accrued interest | $ | $ 2,185 |